| Impact of Rifabutin on the Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor (NCT04840862) | University of Southern California | 2022-05-09 |
| Drug-drug Interactions Between DWP14012 and Aspirin in Healthy Subjects (NCT05304845) | Daewoong Pharmaceutical Co. LTD. | 2022-03-21 |
| Perpetrator DDI Potential of Givinostat as Inhibitor and Inducer of CYP3A and P-gp Activity (NCT05492318) | Italfarmaco | 2022-03-21 |
| Givinostat and Metabolites Pharmacokinetics in Urine and Plasma (Part 3) (NCT05860114) | Italfarmaco | 2022-03-21 |
| The Potential of Givinostat as DDI Victim in Co-administration P-gp Inhibitor (Part 2) (NCT05845567) | Italfarmaco | 2022-03-21 |
| CKD-506 Drug-Drug Interaction Study in Healthy Male Subjects (NCT05238948) | Chong Kun Dang Pharmaceutical | 2022-02-28 |
| The Effect of Dicloxacillin on Oral Absorption of Drugs (NCT05073627) | University of Southern Denmark | 2022-02-07 |
| Drug-Drug Interaction Study to Investigate Effects of Voclosporin on Pharmacokinetics of Simvastatin (NCT05306379) | Aurinia Pharmaceuticals Inc. | 2022-01-24 |
| AV-101 Alone and in Combination With Probenecid in Healthy Subjects (NCT05280054) | VistaGen Therapeutics, Inc. | 2021-12-23 |
| Drug-drug Interaction Between Ciprofol and Mefanamic Acid or Valproate (NCT05181007) | Haisco Pharmaceutical Group Co., Ltd. | 2021-12-17 |
| Drug-drug Interaction Study of SPH3127 (NCT05359055) | Shanghai Pharmaceuticals Holding Co., Ltd | 2021-12-13 |
| Kuwa Free! - Live Free! (NCT05044962) | University of Alabama at Birmingham | 2021-11-26 |
| Evaluation of Pharmacokinetic Drug-drug Interactions Between Hormonal Contraceptives and Doravirine-containing ART Among Women Living With HIV in South Africa (NCT04669678) | University of Alabama at Birmingham | 2021-11-17 |
| Pharmacokinetics of Omeprazole and Midazolam When Co-administered With ACT-1014-6470 (NCT05123820) | Idorsia Pharmaceuticals Ltd. | 2021-11-13 |
| A Drug-Drug Interaction Study Between ATI-2173 and Midazolam or Clarithromycin in Healthy Subjects (NCT05137600) | Antios Therapeutics, Inc | 2021-10-28 |
| Dedicated Drug-Drug Interaction (DDI) Study in Healthy Volunteers (NCT04939467) | Blade Therapeutics | 2021-10-15 |
| Implementation of a Pharmacist-led Pharmacogenomic Clinical Service (NCT04984538) | Tabula Rasa HealthCare | 2021-07-01 |
| Drug-Drug Interaction (DDI) Study in Healthy Volunteers (NCT04814498) | Blade Therapeutics | 2021-05-03 |
| Flucloxacillin as an Inducer of CYP-enzymes (NCT04840641) | University of Southern Denmark | 2021-03-25 |
| Possible Effects of Propylthiouracil, Riociguat and Perphenazine on Circulation of Healthy Volunteers (NCT04776499) | Maastricht University | 2021-03-18 |
| Dihydroartemisinin-Piperaquine in the Context of Antiretroviral Therapy (NCT04487145) | University of California, San Francisco | 2020-11-23 |
| Study to Investigate the Potential Drug-Drug Interaction Between ZSP1273 and Oseltamivir (NCT05108051) | Guangdong Raynovent Biotech Co., Ltd | 2020-11-19 |
| Drug-Drug Interaction Study of Intravenous Administration of SyB V-1901 and Cyclosporine in Japanese Healthy Subjects (NCT04542252) | SymBio Pharmaceuticals | 2020-11-09 |
| Drug to Drug Interaction Study of KBP-5074 in Healthy Subjects (NCT04606537) | KBP Biosciences | 2020-10-24 |
| Drug-Drug Interaction Study of Lorecivivint and Triamcinolone Acetonide in Healthy Volunteers (NCT04598542) | Biosplice Therapeutics, Inc. | 2020-10-13 |
| Pharmacokinetic Interaction Between DWP14012 and DWC202005 in Healthy Volunteers (NCT04328766) | Daewoong Pharmaceutical Co. LTD. | 2020-09-06 |
| Fruquintinib CYP3A Inhibitor and Inducer Study (NCT04557397) | Hutchison Medipharma Limited | 2020-09-02 |
| A Study of the Effect of a Moderate CYP3A Inducer Efavirenz on Quizartinib Pharmacokinetics in Healthy Participants (NCT04459598) | Daiichi Sankyo Co., Ltd. | 2020-08-19 |
| Inhibition Metamizole 2020 (NCT04621253) | University Hospital, Basel, Switzerland | 2020-04-29 |
| Drug-Related Problems in Neonatal Patients (NCT04899960) | Hacettepe University | 2020-02-01 |
| Study to Investigate the Potential Drug-Drug Interaction Between Elafibranor and Indomethacin (NCT03985969) | Genfit | 2019-09-23 |
| Drug-drug Interaction Study Between Edaravone and 2-Aminoethanesulfonic Acid in Compound Edaravone Injection (NCT04218513) | Nanjing Yoko Biomedical Co., Ltd. | 2019-05-10 |
| Drug-Drug Interaction Between Rifampin and Fluvastatin (NCT04029584) | University of California, San Francisco | 2019-04-25 |
| A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib on Metformin (NCT03826602) | Seagen Inc. | 2019-02-12 |
| A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib (NCT03723395) | Seagen Inc. | 2018-09-17 |
| Pharmacokinetic Interactions of Metamizole (Dipyrone) in Healthy Subjects (NCT03990129) | University Hospital, Basel, Switzerland | 2018-09-04 |
| Drug Interaction Study of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male Subjects (NCT03390465) | Boryung Pharmaceutical Co., Ltd | 2017-12-15 |
| A Phase 1 Study to Evaluate the Effects of Omeprazole and Famotidine on the Absorption of Telotristat Ethyl in Healthy Subjects (NCT03302845) | Lexicon Pharmaceuticals | 2017-09-21 |
| A Study to Investigate the Potential Influence of Nitisinone on the Metabolism and the Transport of Other Drugs in Healthy Volunteers (NCT03103568) | Swedish Orphan Biovitrum | 2017-03-28 |
| A Study to Assess the Potential for Pre-systemic Inhibition of CYP3A by Idebenone Using Midazolam as a Substrate (NCT02887443) | Santhera Pharmaceuticals | 2016-09-01 |
| Assessment of Drug-Drug Interactions of Androxal With Cytochrome P450 Isoenyzmes in Healthy Males (NCT01991327) | Repros Therapeutics Inc. | 2014-05-01 |
| A Phase 1, Drug Interaction Study Between AVP-786 and Paroxetine and Between AVP-786 and Duloxetine in Healthy Subjects (NCT02174822) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2014-01-01 |
| The Effects of Multiple Dose Fluoxetine and Metabolites on CYP1A2, CYP2C19, CYP2D6 and CYP3A4 Activity (NCT01361217) | University of Washington | 2011-09-01 |
| Drug-drug Interaction Study With MDV3100 (ASP9785) and Gemfibrozil and Itraconazole (NCT01913379) | Astellas Pharma Europe B.V. | 2011-08-01 |
| Effects of Administration of Fostamatinib on Blood Concentrations of Pioglitazone in Healthy Subjects (NCT01309854) | AstraZeneca | 2011-03-01 |